辛巴斯塔丁改善了血管光滑肌细胞中老化诱导的线粒体功能障碍
C Rossi1, C Macchi1, C D'Alonzo1
1Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Atherosclerosis
|March 29, 2025
概括
辛巴斯塔丁可以改善线粒体功能障碍,并减少衰老相关的分泌表型 (SASP) 在衰老的血管光滑肌细胞 (VSMCs). 这些发现表明simvastatin.
科学领域:
- 衰老的研究研究.
- 细胞衰老 细胞衰老
- 线粒体生物学 线粒体生物学
- 血管生物学 血管生物学
背景情况:
- 衰老和线粒体功能障碍是衰老的关键指标.
- 功能障碍的线粒体与与年龄相关的疾病有关.
- 衰老的血管光滑肌细胞 (VSMCs) 有助于动脉样硬化.
研究的目的:
- 在衰老的VSMC中研究simvastatin的静止效应.
- 分析simvastatin对老化细胞中线粒体质量和功能的影响.
- 探索simvastatin作为治疗年龄相关血管疾病的治疗剂的潜力.
主要方法:
- 在VSMC中使用 doxorubicin 或串行传递诱导衰老.
- 线粒体功能障碍的特征,包括减少的膜潜力和呼吸.
- 对衰老标志物和与衰老相关的分泌表型 (SASP) 的评估.
主要成果:
- 衰老的VSMCs表现出改变的形态,细胞循环抑制剂和功能障碍的线粒体,呼吸减少和ROS增加.
- 西姆瓦斯塔丁 (0.1μM) 降低了SASP和ROS的产生.
- 辛巴斯塔丁在衰老的VSMC中改善了线粒体呼吸,这种效果是由HMG-CoA减少酶抑制介导的.
结论:
- 西姆瓦斯塔丁有效地控制了老化的VSMC中的SASP.
- 辛巴斯塔丁可以改善老化诱导的线粒体功能障碍.
- 这些发现凸显了simvastatin在衰老和血管疾病中的潜在治疗益处.
更多相关视频
相关概念视频
Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...


